Brendan Hannah
CBO, COO & CCO · Quince Therapeutics, Inc.
- 2026
- Jan 24, 2026
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Brendan Hannah files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Luca Benatti - $174K in QNCX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Brendan Hannah?
Brendan Hannah is a corporate insider, tracked as CBO, COO & CCO of Quince Therapeutics, Inc. (QNCX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Brendan Hannah last file a Form 4?
The only primary Form 4 on record is dated 24 January 2026.